Preemptive Antimycotic Treatment in Critically Ill

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25520%2F10%3A39883038" target="_blank" >RIV/00216275:25520/10:39883038 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Preemptive Antimycotic Treatment in Critically Ill
Original language description
The incidence of Candida afflictions in critically ill patients is still growing in the Czech Repulic. We looked for a method that not only decreases Candida afflictions but also decreases treatment expenses. This method is preemptive therapy. Criticallyill patients were determinated by a risk skore systém . This systém was based on summarizing all the risk factors in on patients. Patients who reach the risk score were randomized into groups A and B. Patients in group A were administered Itraconazole,patients in group B were not administered any antimycotics. Results of the study show that preemptive treatment decreases Candida infections and Candidemia. A decrease of tretment expanses was reached by identifying the specific group of patients at riskusing the risk score systém and administering antimycotics.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)